
Correction of astigmatism at the time of cataract surgery

Correction of astigmatism at the time of cataract surgery

Dr Tiziana Fattori of Per Vedere Fatti Vedere onlus in Italy explains the reasons behind the launch of a campaign to abolish bureaucratic procedures inhibiting patients from undertaking treatment for glaucoma.

GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.

The retinal pigment epithelial (RPE) cell mosaic has been imaged for the first time in a living retina using an adaptive optics scanning laser ophthalmoscope (AOSLO), according to a report published in the March issue of Investigative Ophthalmology & Visual Science.

The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times.

Ocular nutraceutical company, EyeScience Labs, LLC, has launched www.EyeScience.com that aims to meet the need for comprehensive information and education on age-related macular degeneration (AMD) in a watch-and-learn video format.

Chlamydia pneumoniae infection, complement factor H variants and AMD

Phakic intraocular lens for the correction of hyperopia

Ophthalmology Times Europe founding editor, Fedra Pavlou, is to become Editor-in-Chief of Pharmaceutical Technology Europe, another of Advanstar's publications. Pamela Brook joins the team as editor of OTE, with immediate effect.

Web-based, interactive approach for teaching the management of angle-closure glaucoma

Correction of residual hyperopia using light adjustable IOL technology

Wide field retinal imaging vs binocular indirect ophthalmoscopy for ROP screening

Abbott Laboratories has completed its acquisition of Advanced Medical Optics (AMO), paying $1.24 billion for 83% of the fully-diluted stock and assuming around $1.4 billion of AMO's long-term debt.

Wavefront-guided retreatment after primary wavefront-guided LASIK in Myopes and Hyperopes

Tube versus trabeculectomy

Low-dose proton beam therpay for circumscibed choroidal hemangiomas

Modified deep sclerectomy for primary open-angle glaucoma

ESBATech AG, a developer of antibody fragment therapeutics, has initiated a Phase IIa study in patients with acute anterior uveitis, designed to evaluate the safety, tolerability and clinical activity of topically applied ESBA105.

Recently, several manufacturers of insulin pens for diabetes treatment have added warnings to the devices, cautioning against their use by visually impaired patients.

We welcome OTE's incoming editor, Pam Brook

An electromagnetic deformable mirror reduces the impact of ocular aberrations on imaging for clearer results, according to Gisele Soubrane.

Aylin Kilic Ertan explores which keratoconus patients are most suitable for treatment with Intacs intracorneal rings.

Dynamic contour tonometry (DCT) may be more accurate than Goldmann applanation tonometry (GAT) in measuring intraocular pressure (IOP), according to study results published in the February issue of Eye.

David Garway-Heath examines HRT output as a component in the early glaucoma detection arsenal.

Young adults judge the age and alertness of older people by looking into and around their eyes, concluded a study published in the February issue of Ophthalmology.

Christopher Girkin discusses how FDT technology predicts disease developments better than SAP.

Jordan Kassoff explains why Epi-LASIK now accounts for nearly 100% of his laser vision correction procedures.

Daniel Mojon studies how strabismus affects the sufferer's ability to find a romantic partner.

Mayank Nanavaty & David Spalton evaluate 17 brands of IOL to discover which has the sharpest "square" edge.

Paul Sternberg assesses the new approaches and exciting pipeline of potential dry AMD treatments.